PRE 14A

PROXY STATEMENT

Company: TENAX THERAPEUTICS, INC.
Filed: October 24, 2013
Period of Report: December 4, 2013
Accession Number: 0001354488-13-005846

View Document ↗ View on SEC.gov ↗